Search

everythinglearnresearchcommunity

for

Search:↓

The Rotterdam Study investigates diseases in older adults and has produced many research findings.

Fluoxetine was not effective in treating hair-pulling disorder in the short term.

Trichotillomania is more common than previously thought, with increasing diagnosed cases.

Despite progress, better treatments and understanding are needed for the high rates of long-term issues and deaths linked to eating disorders.

Anorexia and bulimia lead to serious health problems and increased risk of death, requiring aggressive treatment.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Memantine may slightly improve memory in people with Down syndrome, but more research is needed.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in Tourette syndrome patients.

Finasteride may help reduce tic severity in male Tourette syndrome patients.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in patients with Tourette syndrome.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

People with Seasonal Affective Disorder have different brain activity in certain areas when resting.

Microbial biosurfactants could be a safer and environmentally friendly alternative to chemical surfactants in cosmetics.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.